Riassunto
Il trattamento dell’ipoparatiroidismo è sostanzialmente rivolto alla correzione dello stato di ipocalcemia e iperfosforemia e delle loro conseguenze cliniche. Prima di discutere i provvedimenti terapeutici attualmente disponibili appare opportuno rivedere brevemente alcuni aspetti dell’omeostasi calcica, le cause di ipoparatiroidismo e le sue caratteristiche cliniche.
This is a preview of subscription content, log in via an institution to check access.
Bibliografia
Strewler GJ, Resenblatt M. Mineral metabolism. In: Felig P, Baxter JP, Frohman LA (Eds.) Endocrinology and metabolism. McGraw-Hill, New York, 1995, p 1407.
Sherwoor LM, Santora AC. Hypoparathyroidism states in the differential diagnosis of hypocalcemia. In: Bilezikian JP, Marcus R, Levine MA (Eds.) The parathyroid basic and clinical concepts. Raven Press, New York, 1994, p 747.
Rude RK. Hypocalcemia and hypoparathyroidism. In: Barden CW (Ed.) Current therapy in endocrinology and metabolism. Mosby, St Louis, 1994, p 546.
Okano O, Furukawa Y, Morii H, Fujita T. Comparative efficacy of various vitamine D metabolites in the treatment of various types of hypoparathyroidism. J Clin Endocrinol Metab 55: 238, 1982.
Riordan JLH. Treatment of hypoparathyroidism. In: Bilezikian JP, Marcus R, Levine MA (Eds.) The parathyroid basic and clinical concepts. Raven Press, New York, 1994, p 801.
Wiener KK, Yanovski JA, Sarani B, Cutler GB. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1–34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83: 3480, 1998.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marcocci, C., Vignali, E. Terapia dell’ipoparatiroidismo. L’Endocrinologo 1, 23–30 (2000). https://doi.org/10.1007/BF03344366
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03344366